CTRI/2020/08/027328已完成未知
To Study The Efficacy Of Oral Itraconazole 200mg OD with Topical 1% Terbinafine Cream Versus Oral Itraconazole 200mg OD With Topical 2% Sertaconazole Cream In Dermatophytosis: A Within Person Pilot Study
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adults between the age of 18-65 years, clinically diagnosed as tinea corporis and tinea cruris and confirmed by positive KOH mount microscopy
排除标准
- •Anyone who has taken systemic or topical antifungals in the four weeks prior to initiation of study; or presents with solitary lesion, history of hypersensitivity to antifungals, on any systemic medications known to have interactions with itraconazole, or with superadded bacterial infections, pregnancy or lactating and on immunosuppressive drugs or with any immunosuppressive disease.
研究者
相似试验
尚未招募
3 期
A comparative study between oral itraconazole and terbinafine in tinea infectioCTRI/2023/10/058844Mahatma Gandhi Hospital
已完成
不适用
se of Itraconazole oral solution in Children with Fungal InfectioCTRI/2019/05/019139Dr Ramesh Bhat M30
进行中（未招募）
1 期
Itraconazole as treatment for severe nose bleeding in patients with hereditary hemorrhagic telangiectasiaSevere epistaxis in patients with Hereditary Hemorrhagic Telangiectasia also known as Rendu-Osler-Weber diseaseMedDRA version: 20.0Level: LLTClassification code 10031132Term: Osler-Weber-Rendu diseaseSystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10038554Term: Rendu-Osler-Weber syndromeSystem Organ Class: 100000004850EUCTR2017-003272-31-NLSt. Antonius Ziekenhuis25
已完成
2 期
Efficacy and safety of oral itraconazole in the reduction of epistaxis severity in hereditary hemorrhagic telangiectasiahereditary hemorrhagic telangiectasiaRendu-Osler-Weber disease100075101004704310047075NL-OMON46365Sint Antonius Ziekenhuis25
尚未招募
不适用
To compare the effectiveness of oral itraconazole with low dose and high dose isotretinoin in the treatment of tineaCTRI/2019/06/019600Department of dermatology